Analyst firms · H.C. Wainwright · DVAX

H.C. Wainwright DVAX price target and rating history

Dynavax Technologies Corporation (DVAX) · Health Care

H.C. Wainwright rates Dynavax Technologies Corporation (DVAX) Buy with a $28 price target, as of its latest action on Dec 29, 2021. It has published 3 rating actions on DVAX since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$28
Median target, all firms
Too few
Actions on DVAX
3

H.C. Wainwright price target on DVAX

$28$24$2020222023202420252026
H.C. Wainwright price target on DVAX, each point a stated target, August 2021 to December 2021.

Every H.C. Wainwright rating on DVAX

Questions about H.C. Wainwright and DVAX

What is H.C. Wainwright's price target for DVAX?
H.C. Wainwright's latest stated price target for Dynavax Technologies Corporation (DVAX) is $28, from its action on Dec 29, 2021.
What is H.C. Wainwright's rating on DVAX?
H.C. Wainwright rates DVAX Buy, a bullish rating, as of Dec 29, 2021.
When did H.C. Wainwright last change its view on DVAX?
On Dec 29, 2021, H.C. Wainwright raises its price target to $28 from $23, keeps Buy.

More DVAX rating histories

All H.C. Wainwright ratingsDVAX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.